New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes
Mount Sinai Health SystemStudy outlines better way to identify where stents are necessary
Study outlines better way to identify where stents are necessary
The National Organization for Rare Disorders (NORD) has designated the Division of Medical Genetics and Genomics at The Mount Sinai Hospital as a Rare Disease Center of Excellence.
Joanne L. Stone, MD, a leading physician-scientist in women’s health with special expertise in fetal imaging and caring for high-risk pregnancies, has been named the Chair of Obstetrics, Gynecology, and Reproductive Science for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. Dr. Stone currently serves as Director of the Maternal-Fetal Medicine and Fellowship Program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and immediate past President of the Faculty Council.
Humans are able to think a few steps ahead in non-social situations, such as navigating a new hiking trail or planning a vacation. A Mount Sinai study now shows that we may also do this when interacting with other people.
Deep brain stimulation (DBS) has been demonstrated to be an effective treatment for many patients suffering with treatment-resistant depression, but exactly how it works is not known.
The 32BJ Health Fund and the Mount Sinai Health System today announced expansion of their unique Centers of Excellence program, which provides bariatric and joint replacement surgeries at no-cost to Fund participants, to include partner hospitals in New Jersey, Connecticut, Florida, Massachusetts, and Pennsylvania.
Fast Company announced today its first annual Brands That Matter list, honoring brands that have achieved relevance through cultural impact and social engagement, and authentically communicated their missions and ideals.
Mount Sinai study will inform international strategies to support patients experiencing long-term disability due to condition
The Icahn School of Medicine at Mount Sinai will enroll 11 partner medical schools in its Anti-Racist Transformation (ART) in Medical Education initiative, which seeks to use a formal change management process developed at Mount Sinai to address deeply entrenched racism and bias. The initiative has received generous support from the Josiah Macy Jr. Foundation.
Have you ever experienced a stressful time in your life and then caught a cold, or wondered why you feel sad and depressed when you’re sick? It turns out that it’s not all in your head. Recent research spanning the fields of neuroscience and immunology suggests that when the brain senses a threat in the environment—whether it be physical, psychological, or social—it sends signals via a complex network of peripheral nerves that mobilize the immune system, readying it to protect us from injury.
The Icahn School of Medicine at Mount Sinai is establishing a Skin Biology and Diseases Resource-based Center (SBDRC), funded by a $4 million grant from the National Institutes of Health and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.
Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in Cancer Cell in October.
The Icahn School of Medicine at Mount Sinai has been awarded a five-year, $16 million grant from the National Institutes of Health (NIH) to foster inclusive excellence in the biomedical sciences using evidence-based approaches.
The American Medical Association (AMA) has recognized the Mount Sinai Health System as a recipient of the 2021 Joy in Medicine™ Health System Recognition Program for a demonstrated commitment to preserving the well-being of health care team members by engaging in proven efforts to combat work-related stress and burnout.
Mount Sinai Health System has launched the first eye stroke service in New York City to expedite the diagnosis and treatment of patients who arrive at the emergency room with eye stroke—a medical emergency that must be addressed as quickly as possible to prevent irreversible vision loss.
New department is the first of its kind at a U.S. medical school
Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel machine learning algorithm and used it to identify previously unknown mixtures of toxic air pollutants that appear to be linked to poor asthma outcomes later in a child’s life.
The College of Healthcare Information Management Executives (CHIME) has awarded the Mount Sinai Health System its 2021 CHIME Digital Health Most Wired recognition.
Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and solid tumors, according to a study published in Cancer Discovery in October.
Two Mount Sinai cancer researchers will be awarded $4 million in total costs from the National Institutes of Health (NIH) Common Fund, which supports exceptionally high-impact programs and research by junior scientists around the country.
Mount Sinai has announced the opening of The Charles Lazarus Children’s Abilities Center, which aims to transform and shape the course of children’s rehabilitation.
Empire BlueCross BlueShield (Empire) and Mount Sinai Health System (Mount Sinai) announced today a new agreement focused on delivering care through new models to lower costs and increase value for people throughout New York City.
The Mount Sinai Hospital has been named the No. 1 hospital in specialty care in New York State and one of the top 5 medical centers in the world for gastroenterology, cardiology, and cardiac surgery in Newsweek’s “World’s Best Specialized Hospitals 2022” list.
The Mount Sinai Hospital has been named the No. 1 specialty hospital in New York State and one of the top 5 medical centers in the world for gastroenterology, cardiology, and cardiac surgery in Newsweek’s “World’s Best Specialized Hospitals 2022” list.
The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals today announced the four inaugural grant awardees of the CURE-19 Research Pilot Projects, an initiative to support collaborative, interdisciplinary COVID-19 research to better understand the novel virus that has transformed health care globally.
Mount Sinai researchers have developed a therapy that shows promise against a deadly pediatric leukemia. The small-molecule therapy was highly effective in fighting a type of acute myeloid leukemia in both in vitro and in vivo experiments, according to research published in Science Translational Medicine in September.
Ann-Gel S. Palermo, DrPH, MPH—recognized as an innovative champion for diversity, equity, and inclusion—has been named by Modern Healthcare as one of 2021’s Top Diversity Leaders
Spotting changes in the heart’s electrical activity may prompt more-aggressive treatment and monitoring.
The Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.
A new study finds that more access to daylight at home improves circadian alignment, sleep and mental health in healthy adults.
Recently, the National Institutes of Health (NIH) awarded researchers at the Icahn School of Medicine at Mount Sinai a five-year grant to out whether exposing patients to a combination of light therapies will slow Alzheimer’s debilitating effects.
Only health system in New York State to receive this honor demonstrating exemplary patient care and dedication to advancing treatment
The Mount Sinai Boards of Trustees today announced leadership updates that will position the Mount Sinai Health System for future challenges and opportunities.
Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers
Funds will support cutting-edge MDMA-assisted therapy for PTSD
New York Medical Partners ACO, LLC (NYMP), met quality and cost goals for the management of about 50,000 Medicare beneficiaries in the Medicare Shared Savings Program, resulting in more than $28 million in savings to Medicare, according to recently released performance data from the Centers for Medicare & Medicaid Services (CMS).
New features include upload for COVID-19 vaccination proof and hospital navigation
Researchers at the Icahn School of Medicine at Mount Sinai found that a tool commonly used in research for evaluating a person’s genetic risk for a disease, called a polygenic risk score, was no better at predicting the outcome of a schizophrenia patient’s disease over time than written reports. The results raise important questions about the use of polygenic risk scores in real-world, clinical situations, and also suggest that a doctor’s written report may be an untapped source of predictive information.
Scientists at the Icahn School of Medicine at Mount Sinai described the creation of a new, automated, artificial intelligence-based algorithm that can learn to read patient data from electronic health records. In a side-by-side comparison, they showed that their method, called Phe2vec (FEE-to-vek), accurately identified patients with certain diseases as well as the traditional, “gold-standard” method, which requires much more manual labor to develop and perform
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
In an effort to understand how these states influence the brain’s decision-making processes, scientists at the Icahn School of Medicine at Mount Sinai analyzed the data from a previous pre-clinical study. They found that two of the brain’s decision-making centers contain neurons that may exclusively monitor the body’s internal dynamics. Furthermore, a heightened state of arousal appeared to rewire one of the centers by turning some decision-making neurons into internal state monitors.
For the ninth consecutive year, Mount Sinai will serve as the official medical services provider for the 2021 US Open Tennis Championships, which begin on Monday, August 30, and run through Sunday, September 12.
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial
In a study of rodents, scientists at the Icahn School of Medicine at Mount Sinai discovered that a part of the brain traditionally thought to control typing the old habits may also play a critical role in learning the new actions. The results, published on August 25th in Nature Communications, suggest that this process involves a delicate balance in the activity of two neighboring neural circuits: one dedicated to new actions and the other to old habits
The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.
Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns
In a study to be published this coming Monday, August 23, at 11 am Eastern (please note embargo) in JAMA Internal Medicine, Mount Sinai researchers discuss a troubling rise in homebound older adults that underlines the inequality of the pandemic.